| Post | Subject | | |
|
#230
|
Geneva, Switzerland and Boston, MA – April 7,
|
Frankestin
| 05/18/22 02:29:14 AM |
|
#229
|
ObsEva Announces First Quarter 2022 Financial Results and
|
Pan_O_War
| 05/17/22 06:30:16 AM |
|
#228
|
ObsEva Presents Clinical Data on Oral GnRH Antagonist
|
Pan_O_War
| 05/09/22 06:20:28 AM |
|
#227
|
https://www.globenewswire.com/news-release/2022/05/09/2438181/0/en/ObsEva-Presen
|
Frankestin
| 05/09/22 03:31:58 AM |
|
#226
|
i hope no good news comes out!https://investorshub.advfn.com/uimage/uploads
|
Frankestin
| 05/05/22 01:57:18 PM |
|
#225
|
According to the U.S. National Institutes of Health
|
Frankestin
| 04/22/22 03:40:11 PM |
|
#224
|
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/yselty
|
Frankestin
| 04/22/22 03:21:26 PM |
|
#223
|
https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-opinion-yselty_
|
Frankestin
| 04/22/22 03:20:34 PM |
|
#222
|
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-product
|
Frankestin
| 04/22/22 03:16:18 PM |
|
#221
|
3.6. Initial applications in the decision-making phase
|
Frankestin
| 04/21/22 04:09:36 PM |
|
#220
|
$OBSV ObsEva CEO: «We are planning ObsEva 2.0»
|
Pan_O_War
| 04/13/22 07:13:01 AM |
|
#219
|
https://www.obseva.com/wp-content/uploads/2022/03/ObsEva-Annual-Report-2021.pdf
|
Frankestin
| 04/01/22 02:35:30 AM |
|
#218
|
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/yselty
|
Frankestin
| 03/25/22 06:30:11 AM |
|
#217
|
Elizabeth Garner, MD, MPH, Chief Medical Officer of
|
Frankestin
| 03/22/22 09:00:07 AM |
|
#216
|
ObsEva Announces Additional Efficacy Results for Linzagolix 200
|
Pan_O_War
| 03/22/22 08:22:33 AM |
|
#215
|
ObsEva Announces Year End 2021 Financial Results and
|
Pan_O_War
| 03/10/22 06:03:41 AM |
|
#214
|
Additional data from the 6-month analysis are expected
|
Frankestin
| 03/10/22 04:15:03 AM |
|
#213
|
ObsEva is working with the EMA toward approval,
|
Frankestin
| 03/10/22 04:13:19 AM |
|
#212
|
Article 8 is specific or just general.
|
Pan_O_War
| 02/23/22 06:26:14 AM |
|
#211
|
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-product
|
Frankestin
| 02/22/22 12:55:56 PM |
|
#210
|
They are small but They are the right one!
|
Frankestin
| 02/11/22 04:17:15 AM |
|
#209
|
ObsEva Enters into Licensing Agreement with Theramex for
|
Pan_O_War
| 02/10/22 04:21:50 PM |
|
#208
|
+50,000 Shares Insider buying
|
Pan_O_War
| 02/10/22 05:53:00 AM |
|
#207
|
Let's go!
|
Pan_O_War
| 02/01/22 05:59:32 AM |
|
#206
|
I think now they will make it go up!
|
Frankestin
| 02/01/22 04:31:08 AM |
|
#205
|
Feb. 01, 2022 (GLOBE NEWSWIRE) -- ObsEva SA
|
Frankestin
| 02/01/22 04:21:47 AM |
|
#204
|
Obseva: In January, the Geneva-based biotech company saw
|
Pan_O_War
| 01/31/22 04:47:43 PM |
|
#203
|
XBI ETF is a massive current and gives
|
Pan_O_War
| 01/26/22 09:36:46 AM |
|
#202
|
Insider Buying 1.24.2022 + 50,000 Shares
|
Pan_O_War
| 01/25/22 05:36:27 PM |
|
#201
|
Not sure if my below post is accurate
|
Pan_O_War
| 01/24/22 02:51:43 PM |
|
#200
|
Looks like on the CHMP agenda for decision
|
Pan_O_War
| 01/24/22 12:47:24 PM |
|
#199
|
Amplifying Scientific Innovation®: JPM22 Health Equity, Dr. Elizabeth
|
Pan_O_War
| 01/22/22 09:13:09 AM |
|
#198
|
https://finance.yahoo.com/news/obseva-announces-positive-topline-results-1200004
|
FLY HIGH NOW
| 01/18/22 02:06:10 PM |
|
#197
|
I was expecting some news for this:
|
Frankestin
| 01/14/22 05:15:50 AM |
|
#196
|
Insider buying? (not sure whom):
|
Pan_O_War
| 01/13/22 05:47:52 AM |
|
#195
|
$21.00 Price Target
|
Pan_O_War
| 01/12/22 05:55:01 AM |
|
#194
|
https://www.tipranks.com/experts/analysts/liana-moussatos
|
FLY HIGH NOW
| 01/11/22 07:53:43 PM |
|
#193
|
Endometriosis Drug Shows Promise in Preliminary Phase 3
|
Pan_O_War
| 01/07/22 02:12:54 PM |
|
#192
|
Heavily shorted atm w/about 5 days to cover.
|
Pan_O_War
| 01/07/22 06:03:48 AM |
|
#191
|
NEW 2022 Corporate Presentation here:
|
Pan_O_War
| 01/07/22 05:22:23 AM |
|
#190
|
ObsEva Announces Positive Topline Results for Linzagolix 200
|
Pan_O_War
| 01/06/22 06:10:20 AM |
|
#189
|
https://www.obseva.com/pressrelease-detail/?pr=4786
Once daily linzagolix 200
|
Frankestin
| 01/06/22 04:18:20 AM |
|
#188
|
ObsEva to Present at the H.C. Wainwright BioConnect
|
Pan_O_War
| 01/03/22 04:54:21 AM |
|
#187
|
https://www.globenewswire.com/news-release/2022/01/03/2359807/0/en/ObsEva-to-Pre
|
Frankestin
| 01/03/22 01:17:31 AM |
|
#186
|
7 of the Best Penny Stocks Under $3
|
Pan_O_War
| 01/01/22 04:20:07 AM |
|
#185
|
Yeah - that's the last piece for this year!
|
Pan_O_War
| 12/20/21 11:31:35 AM |
|
#184
|
Good!
waiting for
|
Frankestin
| 12/20/21 05:43:03 AM |
|
#183
|
ObsEva Added to the NASDAQ Biotechnology Index ObsEva
|
Pan_O_War
| 12/20/21 03:44:56 AM |
|
#182
|
Wedbush Reaffirms Their Buy Rating on ObsEva SA
|
Pan_O_War
| 12/19/21 05:37:26 AM |
|
#181
|
https://investorshub.advfn.com/uimage/uploads/2021/12/19/TPQGGVAUVTAMWVKZXB
|
Pan_O_War
| 12/19/21 05:34:18 AM |
| Post | Subject | | |